PRLD Prelude Therapeutics Incorporated Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
12:00
Jul 28 ◎
Pablo CSO, Incyte Corporation INCY Q2 FY26 call
Incyte has a collaboration with Prelude for JAK2V617F assets, but owns the decision on whether to opt in based on data coming from Prelude.
PRLD
HIGH

About PRLD Analyst Coverage

Buzzberg tracks PRLD (Prelude Therapeutics Incorporated) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Pablo.